CCR5 and chronic obstructive pulmonary disease: Similar to our findings, enhanced migratory activity of PBMCs towards CCL5 was observed in chronic obstructive pulmonary disease (COPD) patients compared to those of control subjects (nonsmokers and smokers), while there was no difference in cell surface levels of CCR5 [17].